Virtu KCG Holdings’s Sophiris Bio, Inc. SPHS Stock Holding History

Virtu KCG Holdings’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$61K	Buy	27,562 +2,357	+9%	+$5.77K	﹤0.01%	2543
2017 Q1	$71K	Sell	25,205 -18,435	-42%	-$50.5K	﹤0.01%	2772
2016 Q4	$122K	Buy	43,640 +720	+2%	+$2.04K	﹤0.01%	2839
2016 Q3	$133K	Buy	42,920 +25,907	+152%	+$97.5K	﹤0.01%	2546
2016 Q2	$37K	Sell	17,013 -20,682	-55%	-$28.6K	﹤0.01%	2730
2016 Q1	$54K	Buy	37,695 +21,836	+138%	+$38.5K	﹤0.01%	2451
2015 Q4	$28K	Buy	+15,859	New	+$23.5K	﹤0.01%	3262
2015 Q3	–	Sell	-24,318	Closed	-$19K	–	4317
2015 Q2	$19K	Buy	+24,318	New	+$20.6K	﹤0.01%	3196
2015 Q1	–	Sell	-61,530	Closed	-$33K	–	4512
2014 Q4	$33K	Buy	+61,530	New	+$143K	﹤0.01%	3526
2013 Q4	–	Sell	-11,750	Closed	-$51K	–	4698
2013 Q3	$51K	Buy	+11,750	New	+$54.2K	﹤0.01%	3509

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu KCG Holdings's SPHS Position: Q2 2017 in Review

Virtu KCG Holdings increased its Sophiris Bio, Inc. (SPHS) stake by 9.4% in Q2 2017, buying an estimated $5.77K and bringing the position to 27,562 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #2543.

Virtu KCG Holdings first reported a position in SPHS in Q3 2013 and has held it in 10 quarters since. The position peaked at $133K in Q3 2016. 31 funds tracked by Wall St. Rank hold SPHS as of Q2 2017.

Virtu KCG Holdings held 27,562 shares of Sophiris Bio, Inc. worth $61K as of Q2 2017.
Virtu KCG Holdings bought 2,357 Sophiris Bio, Inc. shares in Q2 2017, an estimated $5.77K.
Sophiris Bio, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2543 holding.
Virtu KCG Holdings first reported a position in Sophiris Bio, Inc. in Q3 2013 and has held it in 10 quarters since.
Virtu KCG Holdings's Sophiris Bio, Inc. position peaked at $133K in Q3 2016.
31 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.